CA3061954A1 - Propulsion et commande d'un microdispositif - Google Patents
Propulsion et commande d'un microdispositif Download PDFInfo
- Publication number
- CA3061954A1 CA3061954A1 CA3061954A CA3061954A CA3061954A1 CA 3061954 A1 CA3061954 A1 CA 3061954A1 CA 3061954 A CA3061954 A CA 3061954A CA 3061954 A CA3061954 A CA 3061954A CA 3061954 A1 CA3061954 A1 CA 3061954A1
- Authority
- CA
- Canada
- Prior art keywords
- main
- cavity
- mse
- threshold
- magnetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 claims abstract description 87
- 230000005291 magnetic effect Effects 0.000 claims description 90
- 210000003495 flagella Anatomy 0.000 claims description 50
- 239000012528 membrane Substances 0.000 claims description 46
- 229920001971 elastomer Polymers 0.000 claims description 41
- 239000000806 elastomer Substances 0.000 claims description 41
- 238000000034 method Methods 0.000 claims description 28
- 238000007789 sealing Methods 0.000 claims description 26
- 230000001225 therapeutic effect Effects 0.000 claims description 21
- 238000002604 ultrasonography Methods 0.000 claims description 12
- 238000001727 in vivo Methods 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 7
- 230000007613 environmental effect Effects 0.000 claims description 6
- 238000000338 in vitro Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 5
- 239000011859 microparticle Substances 0.000 claims description 5
- 239000000411 inducer Substances 0.000 claims description 4
- 239000002105 nanoparticle Substances 0.000 claims description 4
- 238000003384 imaging method Methods 0.000 claims description 3
- 238000012806 monitoring device Methods 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 3
- 230000000149 penetrating effect Effects 0.000 claims description 3
- 238000004880 explosion Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 description 52
- 239000002122 magnetic nanoparticle Substances 0.000 description 13
- 230000035699 permeability Effects 0.000 description 13
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- 239000010408 film Substances 0.000 description 10
- 239000002131 composite material Substances 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 238000013461 design Methods 0.000 description 8
- 239000000696 magnetic material Substances 0.000 description 8
- 239000012781 shape memory material Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000000518 rheometry Methods 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 230000004913 activation Effects 0.000 description 5
- 229910052759 nickel Inorganic materials 0.000 description 5
- 229910000889 permalloy Inorganic materials 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- 210000004081 cilia Anatomy 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000006249 magnetic particle Substances 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- -1 sols Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000005266 casting Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001486 SU-8 photoresist Polymers 0.000 description 2
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 230000005292 diamagnetic effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000005672 electromagnetic field Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 230000005294 ferromagnetic effect Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 238000001459 lithography Methods 0.000 description 2
- 230000005415 magnetization Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 2
- 229920000431 shape-memory polymer Polymers 0.000 description 2
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 2
- XZDLLQQBTVSJJR-UHFFFAOYSA-N 1,3,5-triazaadamantane Chemical class C1N(C2)CN3CC1CN2C3 XZDLLQQBTVSJJR-UHFFFAOYSA-N 0.000 description 1
- WEZDRVHTDXTVLT-GJZGRUSLSA-N 2-[[(2s)-2-[[(2s)-2-[(2-aminoacetyl)amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 WEZDRVHTDXTVLT-GJZGRUSLSA-N 0.000 description 1
- 238000010146 3D printing Methods 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 description 1
- 229910000531 Co alloy Inorganic materials 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 108010009504 Gly-Phe-Leu-Gly Proteins 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 239000002616 MRI contrast agent Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000549556 Nanos Species 0.000 description 1
- 229910052779 Neodymium Inorganic materials 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010043958 Peptoids Proteins 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- 108091027967 Small hairpin RNA Proteins 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000611 antibody drug conjugate Substances 0.000 description 1
- 229940049595 antibody-drug conjugate Drugs 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- 150000001543 aryl boronic acids Chemical class 0.000 description 1
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 1
- 229920005601 base polymer Polymers 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical class OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 239000002961 echo contrast media Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- UCNNJGDEJXIUCC-UHFFFAOYSA-L hydroxy(oxo)iron;iron Chemical compound [Fe].O[Fe]=O.O[Fe]=O UCNNJGDEJXIUCC-UHFFFAOYSA-L 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000005339 levitation Methods 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 244000309459 oncolytic virus Species 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 239000002520 smart material Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229950008461 talimogene laherparepvec Drugs 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000003190 viscoelastic substance Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0116—Steering means as part of the catheter or advancing means; Markers for positioning self-propelled, e.g. autonomous robots
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6861—Capsules, e.g. for swallowing or implanting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0122—Steering means as part of the catheter or advancing means; Markers for positioning with fluid drive by external fluid in an open fluid circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0127—Magnetic means; Magnetic markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1002—Intraluminal radiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0266—Shape memory materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0272—Electro-active or magneto-active materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Robotics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Neurosurgery (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Surgical Instruments (AREA)
- Magnetic Treatment Devices (AREA)
- Prostheses (AREA)
Abstract
La présente invention concerne un dispositif configuré pour se déplacer dans un milieu viscoélastique, le dispositif comprenant : un corps principal comprenant un premier matériau, configuré pour répondre à un premier seuil d'un champ de stimulus ; et un ou plusieurs éléments à mémoire de forme comprenant un deuxième matériau, configuré(s) pour répondre à un deuxième seuil d'un champ de stimuli ; le premier matériau étant sélectionné pour permettre la manipulation de la direction du corps principal dans le milieu viscoélastique ; et le deuxième matériau étant sélectionné pour permettre la manipulation de la configuration de l'élément à mémoire de forme.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762501156P | 2017-05-04 | 2017-05-04 | |
| US62/501,156 | 2017-05-04 | ||
| PCT/US2018/030942 WO2018204687A1 (fr) | 2017-05-04 | 2018-05-03 | Propulsion et commande d'un microdispositif |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3061954A1 true CA3061954A1 (fr) | 2018-11-08 |
Family
ID=64016723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3061954A Pending CA3061954A1 (fr) | 2017-05-04 | 2018-05-03 | Propulsion et commande d'un microdispositif |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20200108227A1 (fr) |
| EP (1) | EP3618815B1 (fr) |
| JP (1) | JP7222980B2 (fr) |
| CA (1) | CA3061954A1 (fr) |
| WO (1) | WO2018204687A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3064423A1 (fr) | 2017-05-29 | 2018-12-06 | Bionaut Labs Ltd. | Declenchement de liberation de charge utile a partir de dispositifs miniaturises |
| US20220409871A1 (en) * | 2019-11-05 | 2022-12-29 | Bionaut Labs Ltd | System and miniature devices for delivering a therapeutic component to a treatment site in a patient |
| JP2023506247A (ja) * | 2019-12-16 | 2023-02-15 | バイオナット ラブス リミテッド | 磁気ミニチュアデバイスおよびそれを遠隔操縦するためのシステム |
| CA3220737A1 (fr) * | 2021-05-21 | 2022-11-24 | Bionaut Labs Ltd. | Systeme et procede de traitement therapeutique localise |
| WO2024010953A1 (fr) * | 2022-07-08 | 2024-01-11 | University Of Utah Research Foundation | Robot magnétique fonctionnel à flexibilité localisée |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6240312B1 (en) * | 1997-10-23 | 2001-05-29 | Robert R. Alfano | Remote-controllable, micro-scale device for use in in vivo medical diagnosis and/or treatment |
| US7591834B2 (en) * | 2004-03-26 | 2009-09-22 | Lawrence Livermore National Security, Llc | Shape memory system with integrated actuation using embedded particles |
| US7998060B2 (en) * | 2004-04-19 | 2011-08-16 | The Invention Science Fund I, Llc | Lumen-traveling delivery device |
| US9067047B2 (en) * | 2005-11-09 | 2015-06-30 | The Invention Science Fund I, Llc | Injectable controlled release fluid delivery system |
| JP4402648B2 (ja) * | 2005-12-16 | 2010-01-20 | オリンパス株式会社 | 被検体内導入装置 |
| KR101083345B1 (ko) * | 2008-05-26 | 2011-11-15 | 전남대학교산학협력단 | 혈관치료용 마이크로 로봇 및 마이크로 로봇 시스템 |
| CN102470237A (zh) * | 2009-06-26 | 2012-05-23 | 塔里斯生物医药公司 | 用于可植入药物递送装置的固体药物片剂 |
| FR2950042B1 (fr) * | 2009-09-17 | 2012-01-13 | Commissariat Energie Atomique | Procede de fabrication d?une microparticule et microparticule ainsi fabriquee |
| US8768501B2 (en) | 2010-05-02 | 2014-07-01 | Max-Planck-Gesellschaft zur Foerderung der Wissenscaften e.V. (MPG) | Magnetic nanostructured propellers |
| KR101303190B1 (ko) * | 2011-11-08 | 2013-09-09 | 전남대학교산학협력단 | 자성체를 포함하는 박테리아-기반 마이크로로봇 |
| WO2013123524A1 (fr) * | 2012-02-16 | 2013-08-22 | The Regents Of The University Of California | Dispositifs de propulsion à l'échelle nano/microscopique déclenchés de manière acoustique |
| TWI522530B (zh) * | 2012-04-09 | 2016-02-21 | 台達電子工業股份有限公司 | 熱磁引擎與熱磁引擎系統 |
| KR101619931B1 (ko) * | 2014-06-10 | 2016-05-13 | 재단법인대구경북과학기술원 | 캡슐형 마이크로 로봇 및 사용방법 |
| US9750923B2 (en) * | 2014-11-19 | 2017-09-05 | Velóce Corporation | Wireless communications system integrating electronics into orally ingestible products for controlled release of active ingredients |
| US10595950B2 (en) * | 2015-04-28 | 2020-03-24 | University Of Washington | Ferromagnetic shaped memory alloy nano-actuator and method of use |
-
2018
- 2018-05-03 CA CA3061954A patent/CA3061954A1/fr active Pending
- 2018-05-03 EP EP18795236.1A patent/EP3618815B1/fr active Active
- 2018-05-03 WO PCT/US2018/030942 patent/WO2018204687A1/fr unknown
- 2018-05-03 JP JP2020511858A patent/JP7222980B2/ja active Active
- 2018-05-03 US US16/609,493 patent/US20200108227A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3618815A4 (fr) | 2021-03-17 |
| EP3618815C0 (fr) | 2023-12-06 |
| EP3618815B1 (fr) | 2023-12-06 |
| EP3618815A1 (fr) | 2020-03-11 |
| JP2020518421A (ja) | 2020-06-25 |
| JP7222980B2 (ja) | 2023-02-15 |
| WO2018204687A1 (fr) | 2018-11-08 |
| US20200108227A1 (en) | 2020-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3618815B1 (fr) | Propulsion et commande d'un microdispositif | |
| Zhang et al. | Voxelated three-dimensional miniature magnetic soft machines via multimaterial heterogeneous assembly | |
| Chung et al. | Magnetically controlled soft robotics utilizing elastomers and gels in actuation: A review | |
| Koleoso et al. | Micro/nanoscale magnetic robots for biomedical applications | |
| Chen et al. | Recent developments in magnetically driven micro-and nanorobots | |
| Bente et al. | Biohybrid and bioinspired magnetic microswimmers | |
| Eshaghi et al. | Design, manufacturing and applications of small-scale magnetic soft robots | |
| Erni et al. | Comparison, optimization, and limitations of magnetic manipulation systems | |
| US20230088973A1 (en) | Propeller and method in which a propeller is set into motion | |
| Wang et al. | Magnetic soft robots: Design, actuation, and function | |
| Bayaniahangar et al. | 3-D printed soft magnetic helical coil actuators of iron oxide embedded polydimethylsiloxane | |
| US20230286048A1 (en) | Method of fabricating a magnetic deformable machine and deformable 3d magnetic machine | |
| Yan et al. | Anisotropic magnetized tubular microrobots for bioinspired adaptive locomotion | |
| Zhu et al. | Biohybrid Magnetic Microrobots: An Intriguing and Promising Platform in Biomedicine | |
| Erin et al. | Design and actuation of a magnetic millirobot under a constant unidirectional magnetic field | |
| Qiu et al. | Magnetic Micro-/Nanopropellers for Biomedicine | |
| Xiang et al. | A theoretical investigation of the ability of magnetic miniature robots to exert forces and torques for biomedical functionalities | |
| US20210275269A1 (en) | Magnetic propulsion mechanism for magnetic devices | |
| Fekete et al. | Magnetic Actuation Methods in Bio/Soft Robotics | |
| Wang et al. | A Tetherless Microdriller for Maneuverability and On-Board Cargo Delivery Inside Viscoelastic Media | |
| Devillers et al. | Magnetic micro-robots for medical applications | |
| Bryan | Assessing the Challenges of Nanotechnology-Driven Targeted Therapies: Development of Magnetically Directed Vectors for Targeted Cancer Therapies and Beyond | |
| Yang et al. | Expansion of Self-assembled Structures of Heteroarray NdFeB Semicircular Arc Magnetic Minirobots | |
| de Oliveira Barros | Modelling, fabrication and characterization of tetherless magnetorheological soft robots | |
| Liu et al. | Soft Millirobot Capable of Switching Motion Modes on the Fly for Targeted Drug Delivery in the Oviduct |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20230502 |
|
| EEER | Examination request |
Effective date: 20230502 |